To evaluate its diagnostic and therapeutic potential, the expression profiles of B7-H3 in pre-malignant lesions, tumor-associated vasculature, metastases, recurrence as well as bodily fluids have to be determined. The gene discussed is CD276; the disease is neoplasm.